|160.81||-1.00||-0.62%||Vol 816.17K||1Y Perf 40.20%|
|Jun 4th, 2020 16:00 DELAYED|
|- -%||- -%|
|Target Price||153.43||Analyst Rating||Hold 2.67|
|Potential %||-4.59||Finscreener Ranking||★+ 44.92|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★+ 46.03|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 65.34|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★+ 37.92|
|Market Cap||23.26B||Earnings Rating||Sell|
|Price Range Ratio 52W %||75.15||Earnings Date||23rd Jul 2020|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||23rd Jul 2020|
|Estimated EPS Next Report||0.96|
|EPS Growth Next 5 Years %||14.00|
|Avg. Weekly Volume||581.25K|
|Avg. Monthly Volume||610.20K|
|Avg. Quarterly Volume||848.98K|
ResMed Inc. (NYSE: RMD) stock closed at 160.81 per share at the end of the most recent trading day (a -0.62% change compared to the prior day closing price) with a volume of 819.36K shares and market capitalization of 23.26B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7240 people. ResMed Inc. CEO is Michael J. Farrell.
The one-year performance of ResMed Inc. stock is 40.2%, while year-to-date (YTD) performance is 3.77%. RMD stock has a five-year performance of 172.44%. Its 52-week range is between 108.85 and 177.99, which gives RMD stock a 52-week price range ratio of 75.15%
ResMed Inc. currently has a PE ratio of 45.70, a price-to-book (PB) ratio of 10.31, a price-to-sale (PS) ratio of 8.06, a price to cashflow ratio of 38.10, a PEG ratio of 2.32, a ROA of 11.91%, a ROC of 15.40% and a ROE of 23.97%. The company’s profit margin is 17.73%, its EBITDA margin is 29.00%, and its revenue ttm is $2.89 Billion , which makes it $19.99 revenue per share.
Of the last four earnings reports from ResMed Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.96 for the next earnings report. ResMed Inc.’s next earnings report date is 23rd Jul 2020.
The consensus rating of Wall Street analysts for ResMed Inc. is Hold (2.67), with a target price of $153.43, which is -4.59% compared to the current price. The earnings rating for ResMed Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
ResMed Inc. has a dividend yield of 0.97% with a dividend per share of $1.56 and a payout ratio of 51.00%.
ResMed Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.53, ATR14 : 5.55, CCI20 : -17.04, Chaikin Money Flow : -0.05, MACD : 0.25, Money Flow Index : 61.90, ROC : -1.08, RSI : 50.48, STOCH (14,3) : 56.86, STOCH RSI : 0.86, UO : 53.10, Williams %R : -43.14), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of ResMed Inc. in the last 12-months were: Brett Sandercock (Sold 32 500 shares of value $4 751 955 ), Carol J. Burt (Sold 10 000 shares of value $1 648 954 ), David B. Pendarvis (Sold 0 shares of value $-2 891 719 ), David B. Pendarvis (Sold 50 267 shares of value $7 371 380 ), David Pendarvis (Sold 0 shares of value $-1 463 011 ), David Pendarvis (Sold 26 202 shares of value $3 453 667 ), James Hollingshead (Sold 0 shares of value $-46 592 ), James Hollingshead (Sold 800 shares of value $98 536 ), James R. Hollingshead (Sold 0 shares of value $-3 093 126 ), James R. Hollingshead (Sold 56 876 shares of value $8 324 062 ), Jim Hollingshead (Sold 0 shares of value $-93 184 ), Jim Hollingshead (Sold 1 600 shares of value $202 136 ), John P. Wareham (Sold 0 shares of value $-1 193 454 ), John P. Wareham (Sold 20 492 shares of value $3 032 967 ), Michael J. Farrell (Sold 0 shares of value $-3 191 840 ), Michael J. Farrell (Sold 74 527 shares of value $10 224 271 ), Rajwant Sodhi (Sold 14 100 shares of value $2 135 369 ), Richard McHale (Sold 18 306 shares of value $2 519 752 ), Robert Andrew Douglas (Sold 0 shares of value $-576 920 ), Robert Andrew Douglas (Sold 25 166 shares of value $3 489 106 ), Robert Douglas (Sold 0 shares of value $-1 009 773 ), Robert Douglas (Sold 32 666 shares of value $4 208 340 ), Ronald R. Taylor (Sold 4 429 shares of value $603 863 )
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.